iSpecimen Presents New Research to Optimize Biobanking at International Society for Biological and Environmental Repositories 2022 Annual Meeting
Company Gave Three Presentations, Including Oral Discussion on How New Technology Can Support the “Just-in-Time” Approach to Biobanking LEXINGTON, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), a globa...
GlobeNewswire · 2d ago
iSpecimen to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022
LEXINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen provid...
GlobeNewswire · 5d ago
iSpecimen GAAP EPS of -$0.27, revenue of $2.5M
iSpecimen press release (NASDAQ:ISPC): Q1 GAAP EPS of -$0.27. Revenue of $2.5M. The reduction in revenue during the quarter was primarily due to the Russia and Ukraine conflict that shut down supply sites in
Seekingalpha · 05/10 12:07
iSpecimen Q1 EPS $(0.27) Up From $(4.23) YoY, Sales $2.50M Miss $2.55M Estimate
iSpecimen (NASDAQ:ISPC) reported quarterly losses of $(0.27) per share. This is a 93.62 percent increase over losses of $(4.23) per share from the same period last year. The company reported quarterly sales of $2.50
Benzinga · 05/10 11:50
-- Earnings Flash (ISPC) ISPECIMEN Posts Q1 Revenue $2.5M, vs. Street Est of $2.72M
MT Newswires · 05/10 07:18
iSpecimen to Report First Quarter 2022 Results on May 10, 2022
LEXINGTON, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global, online marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare providers who h...
GlobeNewswire · 05/02 11:30
PAVM, TBLT and ISPC among mid-day movers
Gainers: Vivakor (VIVK) +91%. Digital World Acquisition (DWAC) +33%. Studio City International Holdings (MSC) +31%. Tempest Therapeutics (TPST) +30%. PAVmed  (PAVM) +17%. AppTech Payments (APCX) +16%. Priority Technology Holdings (PRTH)
Seekingalpha · 04/27 16:50
iSpecimen Unveils Its Enhanced iSpecimen Marketplace Platform
Updated Interface Provides Improved Search and Data Integration Capabilities iSpecimen Marketplace Offers Millions of Biospecimens from Over 200 Providers in the Network LEXINGTON, Mass., April 26, 2022 (GLOBE
Benzinga · 04/26 11:34
iSpecimen Unveils Enhanced iSpecimen Marketplace Platform to Help Scientists More Efficiently Find Desired Biospecimens for Research
Enhanced iSpecimen Marketplace Search Interface iSpecimen’s enhanced Marketplace now enables more precise specimen matching through an easy-to-use interface that allows researchers to search for desired samples via a Google-like search bar, as well as acce...
GlobeNewswire · 04/26 11:30
BRIEF-Ispecimen Adds Acutis Diagnostics To Marketplace Platform To Support Oncology And Infectious Disease Research · 04/13 11:41
CLVR, USX and TKAT among mid-day movers
Gainers: Weidai (WEI) +68%. Manning & Napier (MN) +41%. Chicken Soup for the Soul Entertainment (CSSE) +28%. Hudson Capital (HUSN) +26%. Guardforce AI (GFAI) +19%. U.S. Xpress Enterprises (USX) +20%.
Seekingalpha · 04/01 16:52
iSpecimen to Participate in Maxim’s 2022 Virtual Growth Conference on March 28-30, 2022
LEXINGTON, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global, proprietary online marketplace connecting scientists with healthcare providers to search for biospecimens needed for medical resear...
GlobeNewswire · 03/15 11:30
iSpecimen’s Global Biospecimen Marketplace Surpasses 200 Suppliers
- Proprietary Marketplace Provides Easy Access to Urgently-Needed Tissues, Biofluids and Cells for Lifesaving Medical Research - LEXINGTON, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global, pr...
GlobeNewswire · 03/08 12:30
Quite a few insiders invested in iSpecimen Inc. (NASDAQ:ISPC) last year which is positive news for shareholders
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
Simply Wall St. · 02/24 11:44
Aridis, Rhythm top healthcare gainers; 10x Genomics, iSpecimen lead losers pack
Gainers: Aridis Pharmaceuticals ARDS +12%. Rhythm Pharmaceuticals RYTM +12%. Outset Medical (NASDAQ:OM) +10%. Masimo (NASDAQ:MASI) +8%. Vivos Therapeutics (NASDAQ:VVOS) +7%. Losers: 10x Genomics (NASDAQ:TXG) -16%. iSpecimen ISPC -10%. Poseida Therapeutics ...
Seekingalpha · 02/17 15:05
Benzinga Pro's Top 5 Stocks To Watch For Thursday, Feb. 17, 2022: PLTR, DWAC, GXO, APPS, ISPC
Today's 5 Stock Ideas: Palantir Technologies (PLTR) - The most-mentioned ticker on Reddit's WallStreetBets community. The stock was down 10% following mixed Q4 results. Digital World Acquisition Corp.
Benzinga · 02/17 13:54
iSpecimen GAAP EPS of -$2.09 misses by $0.06, revenue of $11.14M misses by $0.69M
iSpecimen press release (NASDAQ:ISPC): FY GAAP EPS of -$2.09 misses by $0.06. Revenue of $11.14M (+36.2% Y/Y) misses by $0.69M. Shares +6.49% PM.
Seekingalpha · 02/17 12:49
iSpecimen to Participate in the Aegis Virtual Conference on February 24, 2022
LEXINGTON, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD, PhD, CEO and President, will participate in the Ae...
GlobeNewswire · 02/10 12:30
iSpecimen to Report Fourth Quarter and Full Year 2021 Results on February 17, 2022
LEXINGTON, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced that it will report its financial results for the fourth quarter and full year e...
GlobeNewswire · 02/03 12:30
30 Stocks Moving In Friday's Mid-Day Session
Gainers ATI Physical Therapy, Inc. (NYSE: ATIP) shares gained 25.2% to $3.8050 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $3.50 to $5.
Benzinga · 01/14 17:14
Webull provides a variety of real-time ISPC stock news. You can receive the latest news about Ispecimen Inc. through multiple platforms. This information may help you make smarter investment decisions.
About ISPC
iSpecimen Inc. is a technology-driven company. The Company designed iSpecimen Marketplace platform to transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. The Company’s marketplace platform ingests de-identified healthcare data provided by healthcare supply partners. The iSpecimen Marketplace supports the supply chain management and bioprocurement process for specimens and associated data. The Company’s platform helps with administrating and reporting function for researchers, suppliers, and internal personnel, including user and compliance management. The Company serves to biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions.